You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Clinical Decision Making in Patients With IDA and IBD

  • Authors: Gil Y. Melmed, MD, MS
  • CME / ABIM MOC / CE Released: 12/14/2019
  • Valid for credit through: 12/14/2020
Start Activity

Target Audience and Goal Statement

This activity is intended for gastroenterologists, primary care physicians, hematologists, and nurses.

The goal of this activity is to improve clinicians' competence related to screening for iron deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD) and selecting appropriate therapies to improve patients' symptoms and quality of life.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the:
    • Diagnostic criteria for iron deficiency and anemia
  • Demonstrate greater competence in their ability to:
    • Initiate a treatment strategy for IDA in patients with IBD
    • Assess treatment response in patients with IDA
    • Adjust treatments for patients with IBD and IDA when appropriate


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Gil Y. Melmed, MD, MS

    Professor of Medicine
    Director, Inflammatory Bowel Disease Clinical Research
    Co-director, Inflammatory Bowel Disease
    Cedars-Sinai Medical Center
    Los Angeles, California


    Disclosure: Gil Y. Melmed, MD, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for:  Abbvie, Celgene, Janssen, Pfizer, Samsung Bioepis, Takeda


  • Roderick Smith, MS

    Medical Education Director, Medscape, LLC


    Disclosure: Roderick Smith, MS, has disclosed no relevant financial relationships.

CME, CE Reviewer / Nurse Planner

  • Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

    Associate Director, Accreditation and Compliance , Medscape, LLC


    Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity. 

    Contact This Provider

    For Nurses

  • Awarded 1.00 contact hour(s) of continuing nursing education for RNs and APNs; 1.00 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Clinical Decision Making in Patients With IDA and IBD

Authors: Gil Y. Melmed, MD, MSFaculty and Disclosures

CME / ABIM MOC / CE Released: 12/14/2019

Valid for credit through: 12/14/2020


The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

Case 1: Julie, a 33-Year-Old Woman Recently Diagnosed With Ulcerative Colitis

Julie is a 33-year old woman with mild UC that was diagnosed 6 months ago. She recently accepted a job at a law firm in your city and has just moved from out of state. She comes to your office as a new patient and wants to establish care for her UC at your center. You review her history and workup provided by her previous physician. Notably, she was placed on mesalamine therapy at the time of her UC diagnosis. She has been in clinical remission for 4 months. After reviewing Julie's records, you perform a physical examination. She appears to be in good health and has no symptomatic complaints.

  • Print